Catalyst Crew Technologies Corp. (OTC: CCTC) announced it has retained securities attorney Brian Higley to serve as securities counsel to the company. Mr. Higley, based in Utah, advises public companies on corporate governance, securities law compliance, regulatory matters, and capital markets activities. In this role, he will assist the company with ongoing securities law compliance, regulatory filings, and other corporate legal matters as Catalyst Crew Technologies continues executing its strategic transition into artificial intelligence-enabled healthcare technology.
Mr. Higley is listed on the OTC Markets website as one of a limited group of Premium Legal Service Providers, a designation that identifies experienced securities attorneys who assist public companies with regulatory compliance, disclosure matters, and capital markets activities. According to OTC Markets, only nine legal service providers are currently listed within this premium category on the OTC Markets website (https://www.otcmarkets.com). This appointment signals the company's commitment to maintaining appropriate legal and governance frameworks during its strategic evolution.
"Maintaining strong governance and regulatory compliance is an important priority for the company," said Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp. "We are pleased to work with Mr. Higley as we continue strengthening the company's legal and compliance infrastructure as a public company." The engagement reflects the company's continued commitment to maintaining appropriate legal, governance, and regulatory compliance frameworks as it advances its strategic initiatives.
Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.
The appointment of a premium securities counsel carries significant implications for investors and stakeholders. For a company transitioning its business model, robust governance structures provide increased transparency and regulatory compliance, which can enhance investor confidence. The selection of an attorney from the exclusive OTC Markets Premium Legal Service Providers list indicates the company's commitment to meeting higher standards of disclosure and compliance. This move may be particularly important as the company navigates the complex regulatory landscape of both securities law and healthcare technology, two heavily regulated sectors.
Investors can access the company's official filings through the U.S. Securities and Exchange Commission website at https://www.sec.gov, while additional information about the company is available at https://catalystcrewai.com. The company's strategic focus on AI-enabled healthcare technology for emerging markets represents a significant shift in business direction, making strong corporate governance particularly crucial during this transitional period. As healthcare systems worldwide increasingly adopt digital solutions, companies like Catalyst Crew Technologies that combine artificial intelligence with healthcare delivery may play an important role in improving healthcare accessibility and efficiency, especially in regions with developing healthcare infrastructure.
